All In Biotech

Drug Trial Radar · NCT07214896

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

HEALTH: Humanoid Evaluation and Learning Trial in Coalition-Aligned Healthcare Settings

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

400

Planned (sponsor's estimate)

Start

Oct 6, 2025

Primary completion

Oct 6, 2031

Study completion Oct 6, 2031

Sponsor

Lead sponsor
Truway Health, Inc.Industry
Sponsor type
Industry
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Health services research
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Conditions

  • Mobility Impairment
  • Clinical Workflow Optimization
  • Sanitation Protocol Compliance
  • ESG-linked Healthcare Robotics Deployment

Interventions

  • Skin Cell DipBiological

    Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.

  • Stem Cell DipBiological

    iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.

  • Wage Token DistributionOther

    HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.

  • ESG Compliance Monitoring, Operational protocolBehavioral

    Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Biometric Audit Score ≥85 Across Five Performance DimensionsTime frame: Measured at Day 30 Post-Deployment

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016

    New York, New York

  • Coalition Retrofit Clinic - Austin, TX

    Austin, Texas

  • ESG Compliance Lab

    Frankfurt, Germany

  • Public Interface Pilot

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.